is glp 1 safe for kidney disease GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Frontiers | GLP-1 Receptor Agonists
Description
The present study was designed to assess GLP-1-induced diuresis and natriuresis in rats with HF and its interactions with renal nerve activity
Laban Levy is a Partner Attorney with Simon Fitzgerald LLC
Get dedicated support to secure your compensation
Diabetes GLP-1s Show Better Retention but Still Leak Demand GLP-1 therapies prescribed for type 2 diabetes demonstrate stronger patient retention than those indicated for obesity, but the market still faces substantial leakage
By 2022, 44% of women were overweight, and 18% were obese
But for many appropriate patients, the benefits of treating obesity far outweigh the risks of doing nothing
